Chemical Component Summary

Name3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile
Identifiers3-[(3~{S},4~{R})-3-methyl-7-(7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile
FormulaC16 H18 N6 O
Molecular Weight310.354
TypeNON-POLYMER
Isomeric SMILESC[C@H]1CN([C@]12CCN(C2)c3c4cc[nH]c4ncn3)C(=O)CC#N
InChIInChI=1S/C16H18N6O/c1-11-8-22(13(23)2-5-17)16(11)4-7-21(9-16)15-12-3-6-18-14(12)19-10-20-15/h3,6,10-11H,2,4,7-9H2,1H3,(H,18,19,20)/t11-,16-/m0/s1
InChIKeyLOWWYYZBZNSPDT-ZBEGNZNMSA-N

Chemical Details

Formal Charge0
Atom Count41
Chiral Atom Count2
Bond Count44
Aromatic Bond Count10

Drug Info: DrugBank

DrugBank IDDB16133 
NameDelgocitinib
Groups investigational
DescriptionDelgocitinib is under investigation in clinical trial NCT03683719 (Phase 2b Dose-ranging Trial to Evaluate Delgocitinib Cream 1, 3, 8, and 20 Mg/g Compared to Delgocitinib Cream Vehicle Over a 16-week Treatment Period in Adult Subjects With Chronic Hand Eczema).
SynonymsDelgocitinib
CAS number1263774-59-9

Related Resource References

Resource NameReference
Pharos CHEMBL4297507
PubChem 50914062
ChEMBL CHEMBL4297507